JP2025508785A5 - - Google Patents
Info
- Publication number
- JP2025508785A5 JP2025508785A5 JP2024549489A JP2024549489A JP2025508785A5 JP 2025508785 A5 JP2025508785 A5 JP 2025508785A5 JP 2024549489 A JP2024549489 A JP 2024549489A JP 2024549489 A JP2024549489 A JP 2024549489A JP 2025508785 A5 JP2025508785 A5 JP 2025508785A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- halogens
- halogen
- conjugate according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263312554P | 2022-02-22 | 2022-02-22 | |
| US63/312,554 | 2022-02-22 | ||
| PCT/US2023/062996 WO2023164464A1 (en) | 2022-02-22 | 2023-02-22 | 5'-modified carbocyclic ribonucleotide derivatives and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508785A JP2025508785A (ja) | 2025-04-10 |
| JP2025508785A5 true JP2025508785A5 (cg-RX-API-DMAC7.html) | 2026-03-03 |
Family
ID=85778954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024549489A Pending JP2025508785A (ja) | 2022-02-22 | 2023-02-22 | 5’修飾炭素環式リボヌクレオチド誘導体及び使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12636301B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4482845A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025508785A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240169616A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118922431A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023224208A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3252536A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL314850A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023164464A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024081954A2 (en) | 2022-10-14 | 2024-04-18 | Sanegene Bio Usa Inc. | Small interfering rna targeting c3 and uses thereof |
| IL323663A (en) * | 2023-04-06 | 2025-11-01 | Shanghai Argo Biopharmaceutical Co Ltd | Nucleoside analog for 5'-phosphonate modification and oligonucleotide prepared therefrom |
| WO2025191337A2 (en) * | 2024-03-11 | 2025-09-18 | Synerk Biotech Limited | Oligonucleotide terminal phosphate derivatives and method of use |
| WO2026017140A2 (en) | 2024-07-18 | 2026-01-22 | Sanegene Bio Usa Inc. | Small interfering rna targeting fxi and uses thereof |
| WO2026041067A2 (en) | 2024-08-20 | 2026-02-26 | Sanegene Bio Usa Inc. | Small interfering rna targeting myostatin (mstn) and uses thereof |
| WO2026046411A1 (en) | 2024-09-02 | 2026-03-05 | Sanegene Bio Usa Inc. | Small interfering rna targeting plasminogen (plg) and uses thereof |
| US12454693B1 (en) | 2024-09-27 | 2025-10-28 | Dexcel Pharma Technologies Ltd. | Nucleic acids for inhibiting expression of transferrin receptor 2 |
| WO2026092658A2 (en) | 2024-10-31 | 2026-05-07 | Sanegene Bio Usa Inc. | Small interfering rna targeting amyloid beta precursor protein (app) and uses thereof |
| US20260226475A1 (en) | 2025-01-27 | 2026-08-06 | Sanegene Bio Usa Inc. | Small interfering rna targeting acvr1c and uses thereof |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1154A (en) | 1839-05-17 | Spiral-bucket watek-wheel | ||
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5453566A (en) | 1986-03-28 | 1995-09-26 | Calgene, Inc. | Antisense regulation of gene expression in plant/cells |
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| CA1340323C (en) | 1988-09-20 | 1999-01-19 | Arnold E. Hampel | Rna catalyst for cleaving specific rna sequences |
| GB8822492D0 (en) | 1988-09-24 | 1988-10-26 | Considine J | Apparatus for removing tumours from hollow organs of body |
| CA2039718C (en) | 1989-08-31 | 2003-02-25 | John J. Rossi | Chimeric dna-rna catalytic sequences |
| US6365730B1 (en) | 1990-06-19 | 2002-04-02 | Gene Shears Pty. Limited | DNA-Armed ribozymes and minizymes |
| US5789573A (en) | 1990-08-14 | 1998-08-04 | Isis Pharmaceuticals, Inc. | Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2 |
| AU649074B2 (en) | 1990-10-12 | 1994-05-12 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Modified ribozymes |
| DE4216134A1 (de) | 1991-06-20 | 1992-12-24 | Europ Lab Molekularbiolog | Synthetische katalytische oligonukleotidstrukturen |
| US5652094A (en) | 1992-01-31 | 1997-07-29 | University Of Montreal | Nucleozymes |
| CA2135646A1 (en) | 1992-05-11 | 1993-11-25 | Kenneth G. Draper | Method and reagent for inhibiting viral replication |
| JPH07509133A (ja) | 1992-07-17 | 1995-10-12 | リボザイム・ファーマシューティカルズ・インコーポレイテッド | 動物疾患の処置のための方法および剤 |
| IL108367A0 (en) | 1993-01-27 | 1994-04-12 | Hektoen Inst For Medical Resea | Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells |
| US5591317A (en) | 1994-02-16 | 1997-01-07 | Pitts, Jr.; M. Michael | Electrostatic device for water treatment |
| US5631359A (en) | 1994-10-11 | 1997-05-20 | Ribozyme Pharmaceuticals, Inc. | Hairpin ribozymes |
| AU3889595A (en) | 1994-10-05 | 1996-05-02 | Amgen, Inc. | Method for inhibiting smooth muscle cell proliferation and oligonucleotides for use therein |
| US5783683A (en) | 1995-01-10 | 1998-07-21 | Genta Inc. | Antisense oligonucleotides which reduce expression of the FGFRI gene |
| US5747470A (en) | 1995-06-07 | 1998-05-05 | Gen-Probe Incorporated | Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| US5739119A (en) | 1996-11-15 | 1998-04-14 | Galli; Rachel L. | Antisense oligonucleotides specific for the muscarinic type 2 acetylcholine receptor MRNA |
| CA2518475C (en) | 2003-03-07 | 2014-12-23 | Alnylam Pharmaceuticals, Inc. | Irna agents comprising asymmetrical modifications |
| EP2669377A3 (en) | 2003-04-17 | 2015-10-14 | Alnylam Pharmaceuticals Inc. | Modified iRNA agents |
| AU2006279906B2 (en) | 2005-08-10 | 2012-05-10 | Alnylam Pharmaceuticals, Inc. | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| US20070213292A1 (en) | 2005-08-10 | 2007-09-13 | The Rockefeller University | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| EP2229186A2 (en) | 2007-12-04 | 2010-09-22 | Alnylam Pharmaceuticals Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
| WO2011139699A2 (en) | 2010-04-28 | 2011-11-10 | Isis Pharmaceuticals, Inc. | 5' modified nucleosides and oligomeric compounds prepared therefrom |
| WO2011139702A2 (en) * | 2010-04-28 | 2011-11-10 | Isis Pharmaceuticals, Inc. | Modified nucleosides and oligomeric compounds prepared therefrom |
| RU2582235C2 (ru) | 2010-12-29 | 2016-04-20 | Ф.Хоффманн-Ля Рош Аг | Низкомолекулярные конъюгаты для внутриклеточной доставки нуклеиновых кислот |
| US8577565B2 (en) | 2011-12-16 | 2013-11-05 | GM Global Technology Operations LLC | Limiting branch pressure to a solenoid valve in a fluid circuit |
| EP2958998B1 (en) * | 2013-02-22 | 2017-12-27 | Sirna Therapeutics, Inc. | Short interfering nucleic acid (sina) molecules containing a 2' internucleoside linkage |
| WO2015006740A2 (en) | 2013-07-11 | 2015-01-15 | Alnylam Pharmaceuticals, Inc. | Oligonucleotide-ligand conjugates and process for their preparation |
| EP3865576A1 (en) | 2014-12-15 | 2021-08-18 | Dicerna Pharmaceuticals, Inc. | Ligand-modified double-stranded nucleic acids |
| TWI912633B (zh) | 2016-06-06 | 2026-01-21 | 美商愛羅海德製藥公司 | 5'-環-磷酸修飾之核苷酸 |
| MX2019002075A (es) | 2016-08-23 | 2019-07-01 | Dicerna Pharmaceuticals Inc | Composiciones que comprenden oligonucleotidos modificados reversiblemente, y sus usos. |
| WO2018045317A1 (en) | 2016-09-02 | 2018-03-08 | Dicerna Pharmaceuticals, Inc. | 4'-phosphate analogs and oligonucleotides comprising the same |
-
2023
- 2023-02-22 IL IL314850A patent/IL314850A/en unknown
- 2023-02-22 CN CN202380029632.8A patent/CN118922431A/zh active Pending
- 2023-02-22 KR KR1020247030954A patent/KR20240169616A/ko active Pending
- 2023-02-22 AU AU2023224208A patent/AU2023224208A1/en active Pending
- 2023-02-22 JP JP2024549489A patent/JP2025508785A/ja active Pending
- 2023-02-22 US US18/172,719 patent/US12636301B2/en active Active
- 2023-02-22 CA CA3252536A patent/CA3252536A1/en active Pending
- 2023-02-22 WO PCT/US2023/062996 patent/WO2023164464A1/en not_active Ceased
- 2023-02-22 EP EP23714023.1A patent/EP4482845A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024529067A5 (cg-RX-API-DMAC7.html) | ||
| JP2024534502A5 (cg-RX-API-DMAC7.html) | ||
| JP7740719B2 (ja) | ホスホルアミダイト化学を使用する骨格修飾モルホリノオリゴヌクレオチド及びキメラの合成 | |
| JP7008056B2 (ja) | 修飾されたサブユニット間結合および/または末端基を有するオリゴヌクレオチドアナログ | |
| JP2025041652A5 (cg-RX-API-DMAC7.html) | ||
| US9273086B2 (en) | Protected monomer and method of final deprotection for RNA synthesis | |
| US10066228B2 (en) | Oligonucleotides for treating expanded repeat diseases | |
| ES2924806T3 (es) | Análogos de 4'-fosfato y oligonucleótidos que comprenden el mismo | |
| US12503698B2 (en) | GalNAc derivatives | |
| CN106188192B (zh) | 含d-氨基酸酯的核苷氨基磷酸/膦酸酯衍生物及其医药用途 | |
| CN1964967B (zh) | 路易斯酸介导的环状酯的合成 | |
| JP2023541427A (ja) | 骨格筋送達プラットフォーム及び使用方法 | |
| JP2021533800A5 (cg-RX-API-DMAC7.html) | ||
| JP2021535226A5 (cg-RX-API-DMAC7.html) | ||
| JP2022535911A5 (cg-RX-API-DMAC7.html) | ||
| US20120184724A1 (en) | Protected monomers and methods of deprotection for rna synthesis | |
| US20170362270A1 (en) | Modified oligonucleotides and methods for their synthesis | |
| JP2015501817A5 (cg-RX-API-DMAC7.html) | ||
| JP2022527569A5 (cg-RX-API-DMAC7.html) | ||
| JP2021522862A5 (cg-RX-API-DMAC7.html) | ||
| JP2015063538A (ja) | ヌクレオシドホスホナートが投与された被験者における腎毒性を減少させる方法 | |
| JP2024546667A5 (cg-RX-API-DMAC7.html) | ||
| CA2436665A1 (en) | Nucleic acid derivatives | |
| CN104023751B (zh) | 靶向递送至表达vla-4的细胞的整联蛋白拮抗剂结合物 | |
| US6900307B1 (en) | 2-aminopurine derivatives |